Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of eplerenone, a selective aldosterone blocker, and amlodipine, a calcium channel blocker. This combination is used primarily for treating hypertension. Eplerenone works by blocking the action of aldosterone, a natural substance that raises blood pressure, while amlodipine relaxes blood vessels and improves blood flow. Studies have shown that this combination may provide complementary effects in treating hypertension and protecting against cardiovascular injury in salt-sensitive hypertension. The combination has shown particular benefits in patients with microalbuminuria, suggesting potential renal protective effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on eplerenone + amlodipine.